研究人员创造出超弹性、自我修复材料,将改善人造肌肉

医疗器械 来源:中国科技网 作者:编译:张微
2016
04/20
09:48
中国科技网
作者:编译:张微
医疗器械

如果说这个世界上有完美的实验,那么斯坦福大学化学工程教授Zhenan Bao最近的努力就完全符合要求。

她团队的一位成员,Cheng-Hui Li想要测试他刚刚合成的弹性体的延展性(这种材料是一种橡胶类的塑料)。这种材料通常可以拉伸到其原始长度的两到三倍,还能回弹到它原来的尺度。一个普通的压力测试包括一直拉伸这种弹性体直到超过它的断裂点。

但是Li,一位来自中国的访问学者,遇到了意外的困难:夹具通常测量的弹性只能拉伸到45英寸。想要找到一英寸长的样本的断裂点,Li和另一位实验室成员各持一端,然后各自后退,最后将这个一英寸长的聚合物膜拉伸到100英寸以上。

Bao惊呆了。

“我说,‘这怎么可能?你肯定吗?’”她回忆说。

在今天发表的《自然化学》期刊上,研究人员解释了他们是如何制造这种超弹性物质的。他们还表示,他们可以通过将其暴露在电场中,引起它的扩张和收缩,从而让这个新的弹性体抽动,开发其作为人造肌肉的潜在利用价值。

目前,人造肌肉在消费技术和机器人领域都有应用,但是与真正的肌肉相比,它们有很多缺点,Bao说。目前,用于制造人造肌肉的材料上的小洞或缺陷会让材料失去弹性。如果被刺穿或划伤,它们也无法进行自我修复。

但是这种新材料,除了具有非凡的延展性之外,还具有显着的自愈特性。损坏的聚合物通常需要溶剂或热处理才能恢复性能,但是这种新材料在室温下,即使已经损坏好几天的时间,依然表现出了令人赞叹的自我修复能力。实际上,科研人员发现,它在零下4华氏度(零下20℃)或者在商业冷藏库的温度下也能自我修复。

该团队将新材料的这种非凡的延展性和自我修复能力归因于交叉链接(一种化学粘合法)的一些关键改进。这个过程是指渔网状连接的分子连接成为直链,让聚合物产生了十倍的拉伸能力。

首先,他们设计了一种特殊的有机分子,在交叉链接过程中附着在短聚合物链上,来创造一系列的配体结构。这些配体结合在一起形成长聚合物链——具有内在张力的弹簧圈。

然后,他们在材料中加入金属离子,这些离子对于配体来说具有化学亲和性。当这种复合材料处于受力状态,金属离子和配体之间的化学亲和性就会将网状的分子结构拉紧。其结果就得到了强大的、可伸缩的、自我修复的弹性体。

“聚合物通过金属离子和配体之间的亲和性链接在一起,好像一个大网一样,”Bao解释道。“每一个金属离子至少与两个配体结合,因此,即使一个配体的一端断裂,金属离子仍然可以与配体的另一端相连。当压力被释放时,离子可以很轻松地域另一个配体重新连接,如果它们足够靠近的话。”

研究团队发现,他们可以通过改变金属离子的加入量来调节聚合物,让它变得更有弹性或自愈的更快。这个版本的材料超出了机器的测量范围,例如,通过降低聚合物中铁原子和材料中有机分子的比例就可以创造出新的版本。

研究人员还表明,这种添加金属的新聚合物能够在电场中抽动。他们还要做更多的工作来增加材料的扩张和收缩程度,从而更加精确地控制它。这一研究为未来有前景的应用开启了大门。

除了其作为人造肌肉的长期潜在利用,这项研究还能用于帮助使用假肢的人恢复部分感知能力。在之前的研究中,她的研究团队创造了了灵活但脆性强的聚合物,上面镶有压力传感器,来探测握手和蝴蝶降落的差异。这种新的、耐用材料可以开发成为人造皮肤物理结构的一部分。

“人造皮肤不是由一种材料制成的,”Franziska Lissel说,他是Bao实验室的博士后研究员,也是该研究团队的成员。“我们想要创造一个非常复杂的系统。”

即使在人造肌肉和人工皮肤变成实用性技术之前,这项工作也非常重要,强大、灵活和电子活性聚合物的开发,能够引发新一代的可穿戴电子产品,或者能够制造使用很长时间不需要修理或更换的医疗植入物。

Researchers create super stretchy, self-healing material that could lead to artificial muscle

If there's such a thing as an experiment that goes too well, a recent effort in the lab of Stanford chemical engineering Professor Zhenan Bao might fit the bill.

One of her team members, Cheng-Hui Li, wanted to test the stretchiness of a rubberlike type of plastic known as an elastomer that he had just synthesized. Such materials can normally be stretched two or three times their original length and spring back to original size. One common stress test involves stretching an elastomer beyond this point until it snaps.

But Li, a visiting scholar from China, hit a snag: The clamping machine typically used to measure elasticity could only stretch about 45 inches. To find the breaking point of their one-inch sample, Li and another lab member had to hold opposing ends in their hands, standing further and further apart, eventually stretching a 1-inch polymer film to more than 100 inches.

Bao was stunned.

“I said, 'How can that be possible? Are you sure?‘” she recalled.

Today in Nature Chemistry, the researchers explain how they made this super-stretchy substance. They also showed that they could make this new elastomer twitch by exposing it to an electric field, causing it to expand and contract, making it potentially useful as an artificial muscle.

Artificial muscles currently have applications in some consumer technology and robotics, but they have shortcomings compared to a real bicep, Bao said. Small holes or defects in the materials currently used to make artificial muscle can rob them of their resilience. Nor are they able to self-repair if punctured or scratched.

But this new material, in addition to being extraordinarily stretchy, has remarkable self-healing characteristics. Damaged polymers typically require a solvent or heat treatment to restore their properties, but the new material showed a remarkable ability to heal itself at room temperature, even if the damaged pieces are aged for days. Indeed, researchers found that it could self-repair at temperatures as low as negative 4 degrees Fahrenheit (-20 C), or about as cold as a commercial walk-in freezer.

The team attributes the extreme stretching and self-healing ability of their new material to some critical improvements to a type of chemical bonding process known as crosslinking. This process, which involves connecting linear chains of linked molecules in a sort of fishnet pattern, has previously yielded a tenfold stretch in polymers.

First they designed special organic molecules to attach to the short polymer strands in their crosslink to create a series of structure called ligands. These ligands joined together to form longer polymer chains – spring-like coils with inherent stretchiness.

Then they added to the material metal ions, which have a chemical affinity for the ligands. When this combined material is strained, the knots loosen and allow the ligands to separate. But when relaxed, the affinity between the metal ions and the ligands pulls the fishnet taut. The result is a strong, stretchable and self-repairing elastomer.

“Basically the polymers become linked together like a big net through the metal ions and the ligands,” Bao explained. “Each metal ion binds to at least two ligands, so if one ligand breaks away on one side, the metal ion may still be connected to a ligand on the other side. And when the stress is released, the ion can readily reconnect with another ligand if it is close enough.”

The team found that they could tune the polymer to be stretchier or heal faster by varying the amount or type of metal ion included. The version that exceeded the measuring machine's limits, for example, was created by decreasing the ratio of iron atoms to the polymers and organic molecules in the material.

The researchers also showed that this new polymer with the metal additives would twitch in response to an electric field. They have to do more work to increase the degree to which the material expands and contracts and control it more precisely. But this observation opens the door to promising applications.

In addition to its long-term potential for use as artificial muscle, this research dovetails with Bao's efforts to create artificial skin that might be used to restore some sensory capabilities to people with prosthetic limbs. In previous studies her team has created flexible but fragile polymers, studded with pressure sensors to detect the difference between a handshake and a butterfly landing. This new, durable material could form part of the physical structure of a fully developed artificial skin.

“Artificial skin is not just made of one material,” said Franziska Lissel, a postdoctoral fellow in Bao's lab and member of the research team. “We want to create a very complex system.”

Even before artificial muscle and artificial skin become practical, this work in the development of strong, flexible, electronically active polymers could spawn a new generation of wearable electronics, or medical implants that would last a long time without being repaired or replaced.

来源:中国科技网   作者:编译:张微

为你推荐

拓展入境健康消费,探索建设国际医疗旅游集聚区资讯

拓展入境健康消费,探索建设国际医疗旅游集聚区

统筹中国游、中国购、中国学、中国医等多维体验,系统构建“你好!中国”国家旅游形象,打造“中国游”品牌。

2026-03-21 20:47

DRG/DIP 3.0 的最新消息资讯

DRG/DIP 3.0 的最新消息

2026年3月19日上午,国家医保局开展按病种付费分组方案3 0版调整情况介绍活动。

2026-03-20 22:32

创新“无棉”静音技术,可孚医疗发布首款智能呼吸机资讯

创新“无棉”静音技术,可孚医疗发布首款智能呼吸机

3月20日,正值世界睡眠日到来之际,可孚医疗隆重举行呼吸机新品发布会,正式推出行业率先实现的无消音棉超静音AI智能呼吸机——C11。

2026-03-20 19:02

NVIDIA GTC 大会重磅发布:以 AI 与算力赋能药物研发全链路创新资讯

NVIDIA GTC 大会重磅发布:以 AI 与算力赋能药物研发全链路创新

在 GTC 大会上,NVIDIA 集中展示了其在制药与生命科学领域的核心技术成果与深度行业合作

2026-03-20 14:21

深耕肾病与代谢领域,炫景生物完成超2亿元Pre-A轮融资资讯

深耕肾病与代谢领域,炫景生物完成超2亿元Pre-A轮融资

本轮融资由康君资本领投,德联资本、华泰金斯瑞基金、金易赋新、国海创新资本、联想创投等机构联合参投,现有股东元希海河继续跟投

2026-03-20 13:52

先衍生物完成1.5亿元A轮融资,加速小核酸药物核心技术突破与管线推进资讯

先衍生物完成1.5亿元A轮融资,加速小核酸药物核心技术突破与管线推进

本轮融资由道远资本领投,启申创投联合领投,嘉乐资本、成都科创投集团、四川省中试研发有限公司、厦门高新投、增锐铭禾等机构跟投,同时成都先导、银满基金、怀格资本、钧天创...

2026-03-20 13:48

聚焦“三高一疹”共病联防,“乐龄健康第一课”全面升级、在沪开讲资讯

聚焦“三高一疹”共病联防,“乐龄健康第一课”全面升级、在沪开讲

多领域专家齐聚沪上“文化会客厅”,共话“小处方”背后的温情守护

2026-03-20 13:32

华海药业PD-L1/VEGF将正式启动子宫内膜癌的Ⅲ期临床试验资讯

华海药业PD-L1/VEGF将正式启动子宫内膜癌的Ⅲ期临床试验

3月19日,华海药业发布公告称,近日,下属子公司上海华奥泰生物药业股份有限公司就HB0025联合化疗一线治疗晚期 复发子宫内膜癌经过与国家药品监督管理局药品审评中心(CDE)Ⅱ...

2026-03-20 10:40

天宜康医药完成逾亿元种子轮融资,汪文博士领衔攻坚CAR-T行业核心痛点资讯

天宜康医药完成逾亿元种子轮融资,汪文博士领衔攻坚CAR-T行业核心痛点

本轮融资由弘毅投资和幂方健康基金共同领投,苏创投、承树投资、英贤投资及毅达资本跟投

2026-03-19 13:19

爱尔康披露关键数据:全球老视矫正型人工晶体植入量超600万枚,人工晶体植入总量突破1.75亿枚资讯

爱尔康披露关键数据:全球老视矫正型人工晶体植入量超600万枚,人工晶体植入总量突破1.75亿枚

全球人工晶体(IOL)植入技术在临床应用中不断取得新进展,为患者术后视觉质量的提升提供了更多可能性。

2026-03-19 13:08

赛诺菲首个中国创新与运营中心落户成都资讯

赛诺菲首个中国创新与运营中心落户成都

汇聚本土人才,赋能数字生态,共促医药创新转型升级

2026-03-19 13:04

沃森生物明天复牌,实控人变更资讯

沃森生物明天复牌,实控人变更

公司控股股东将变更为腾云新沃,实际控制人变更为黄涛,自此沃森生物结束16年的无实际控制人状态。

2026-03-18 23:09

4款药品再次被上海列为重点监控品种资讯

4款药品再次被上海列为重点监控品种

3月17日,上海市医药集中招标采购事务管理所发布最新重点监控药品名单,共计10款,包括利肺片、注射用二羟丙茶碱、肝素钙注射液等。重点监控品种主要针对采购金额高、价格异常或...

2026-03-18 21:20

直观复星支持开展“儿童公益救助项目”,助力先进医疗技术惠及更多患儿资讯

直观复星支持开展“儿童公益救助项目”,助力先进医疗技术惠及更多患儿

3月18日,手术机器人领军企业直观复星正式向上海市医药卫生发展基金会进行公益捐赠,专项支持“儿童公益救助项目”

2026-03-18 18:03

礼邦医药 AP306 出海 资讯

礼邦医药 AP306 出海

根据协议,礼邦医药已授予 R1 在大中华区以外地区独家开发、生产及商业化 AP306 的权利。协议项下的整体经济条款包括最高总计过亿美元的开发、注册及商业化里程碑付款;同时...

2026-03-18 15:59

百度健康计划近期推出DoctorClaw资讯

百度健康计划近期推出DoctorClaw

据悉这是一款面向医生的OpenClaw,定位是医生AI助理,可以帮医生自动整理研究资料、跟踪论文进度、设置随访提醒、定时追踪最新文献等。

2026-03-18 11:45

基层医疗卫生机构可单次开具不超过12周用药的长期处方资讯

基层医疗卫生机构可单次开具不超过12周用药的长期处方

3月16日,国家医保局会同国家发展改革委、国家卫生健康委印发《关于医保支持基层医疗卫生服务发展的指导意见》。

2026-03-17 21:03

传奇生物被传拟赴港上市资讯

传奇生物被传拟赴港上市

日前有媒体报道引述知情人士称,传奇生物拟赴港上市,最早将于今年(2026年)落地,募资规模约3亿至4亿美元(约折合港元23 4亿至31 2亿)。对此,3月17日,传奇生物方面表示,...

2026-03-17 13:20

男子回家遭自家狗撕咬,伤口深可见骨!专家紧急提醒:暴露后规范处置是关键资讯

男子回家遭自家狗撕咬,伤口深可见骨!专家紧急提醒:暴露后规范处置是关键

狂犬病是由狂犬病病毒引起的一种以侵犯中枢神经系统为主的急性人兽共患传染病。其主要临床表现为特异性恐风、恐水、咽肌痉挛、进行性瘫痪等。

2026-03-17 12:42